Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | RMC-4550 |
Trade Name | |
Synonyms | |
Drug Descriptions |
RMC-4550 is a small molecule allosteric inhibitor of Shp2 that blocks Ras-Raf-Mek-Erk pathway signaling, leading to tumor growth inhibition (PMID: 30104724). |
DrugClasses | SHP2 Inhibitor 14 |
CAS Registry Number | 2172651-73-7 |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Adagrasib + RMC-4550 | Adagrasib RMC-4550 | 0 | 0 |
Alectinib + RMC-4550 | Alectinib RMC-4550 | 1 | 0 |
BAY-293 + Osimertinib + RMC-4550 | BAY-293 Osimertinib RMC-4550 | 0 | 0 |
BAY-293 + RMC-4550 | BAY-293 RMC-4550 | 0 | 0 |
Crizotinib + RMC-4550 | Crizotinib RMC-4550 | 0 | 0 |
Osimertinib + RMC-4550 | Osimertinib RMC-4550 | 0 | 0 |
RMC-4550 | RMC-4550 | 6 | 0 |
RMC-4550 + Sotorasib | RMC-4550 Sotorasib | 0 | 0 |